Photocure ASA
Develops and commercializes photodynamic technology for bladder cancer.
PHO | OL
Overview
Corporate Details
- ISIN(s):
- NO0010000045
- LEI:
- 5967007LIEEXZXG8OW35
- Country:
- Norway
- Address:
- HOFFSVEIEN 4, 0275 OSLO
- Website:
- https://www.photocure.com/
- Sector:
- Manufacturing
Description
Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-09-25 11:59 |
Major shareholder disclosure in Photocure ASA
|
English | 289 bytes | ||
| 2023-09-20 10:17 |
Photocure Partner Asieris announces that the First Non-Vaccine Investigational …
|
English | 135.6 KB | ||
| 2023-09-20 10:17 |
Photocure Partner Asieris announces that the First Non-Vaccine Investigational …
|
English | 6.8 KB | ||
| 2023-08-30 14:06 |
Photocure ASA: Notification of primary insider transaction
|
Norwegian | 122.9 KB | ||
| 2023-08-30 14:06 |
Photocure ASA: Notification of primary insider transaction
|
English | 108.1 KB | ||
| 2023-08-30 14:06 |
Photocure ASA: Notification of primary insider transaction
|
English | 1.4 KB | ||
| 2023-08-11 09:05 |
Photocure Partner Asieris confirms Hexvix Phase III clinical trial in China mee…
|
English | 113.1 KB | ||
| 2023-08-11 09:05 |
Photocure Partner Asieris confirms Hexvix Phase III clinical trial in China mee…
|
English | 7.6 KB | ||
| 2023-08-09 06:00 |
Photocure ASA: Results for the second quarter and first half of 2023
|
English | 841.6 KB | ||
| 2023-08-09 06:00 |
Photocure ASA: Results for the second quarter and first half of 2023
|
English | 977.7 KB | ||
| 2023-08-09 06:00 |
Photocure ASA: Results for the second quarter and first half of 2023
|
English | 203.4 KB | ||
| 2023-08-09 06:00 |
Photocure ASA: Results for the second quarter and first half of 2023
|
English | 7.7 KB | ||
| 2023-08-08 12:26 |
Major shareholder disclosure in Photocure ASA
|
English | 175.7 KB | ||
| 2023-08-08 12:26 |
Major shareholder disclosure in Photocure ASA
|
English | 296 bytes | ||
| 2023-08-03 06:13 |
Photocure ASA: Invitation to presentation of second quarter and first half year…
|
English | 2.4 KB |
Automate Your Workflow. Get a real-time feed of all Photocure ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Photocure ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Photocure ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
